[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336809-105":59,"doc-detail-336809-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-tumor-microenvironment-in-molecular-subtyping-and-prognostic-signatures-in-ovarian-cancer-and-identification-of-sh2d1a-as-a-key-regulator-of-ovarian-cancer-carcinogenesis","Exploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis","","A study investigates ovarian cancer (OV), a deadly gynecological malignancy with poor outcomes driven by late-stage diagnosis and limited targeted therapies. Tumor microenvironment (TME) signals are evaluated as a key driver of solid tumor progression. Bulk and single-cell transcriptomic datasets are integrated, molecularly stratifying tumors into two consensus subgroups and building a multi-dataset TME-related prognostic model. The work identifies SH2D1A as a pivotal regulator, and experimental knockdown reduces OV cell migration and proliferation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-tumor-microenvironment-in-molecular-subtyping-and-prognostic-signatures-in-ovarian-cancer-and-identification-of-sh2d1a-as-a-key-regulator-of-ovarian-cancer-carcinogenesis/336809/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-tumor-microenvironment-in-molecular-subtyping-and-prognostic-signatures-in-ovarian-cancer-and-identification-of-sh2d1a-as-a-key-regulator-of-ovarian-cancer-carcinogenesis/336809.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is ovarian cancer prognosis poor in this study?","Question",{"text":112,"@type":113},"Ovarian cancer has a poor prognosis due to late-stage diagnosis and the limited availability of effective targeted therapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were ovarian cancer molecular subgroups identified?",{"text":117,"@type":113},"Bulk RNA-seq data from multiple cohorts were clustered using consensus clustering to derive two molecularly distinct groups (C1 and C2) based on TME-related gene set expression.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does SH2D1A play according to the study?",{"text":121,"@type":113},"SH2D1A is highlighted as a key regulator of ovarian cancer carcinogenesis. Its knockdown in ovarian cancer cell lines reduces migration and proliferation in vitro.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336809,1790979488,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Heliyon 10 (2024) e38014  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \nResearch article  \nExploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis  \nHongrui Guo a, liwen Zhang b, Huancheng Sua, Jiaolin Yanga, Jing Leia, Xiaoli Li b,**, Sanyuan Zhang a,***, Xinglin Zhang a,*  \na Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China b Department of Gynecology, The Children’s Hospital of Shanxi, Taiyuan, 030001, China  \nA R T I C L E I N F O  \nKeywords:  \nOvarian cancer  \nTumor microenvironment Prognosis  \nMulti-omics Machine learning SH2D1A Migration Proliferation  \nA B S T R A C T  \nIntroduction: A deadly gynecological cancer, ovarian cancer (OV), has a poor prognosis because of late-stage diagnosis and few targeted therapies. Addressing the tumor microenvironment (TME) in solid tumors has shown promise since it is crucial in promoting cancer progression.  \nMethods: We obtained bulk RNA-seq data from TCGA-OV, GSE26712, GSE102073, and ICGC cohorts, as well as scRNA-seq data from EMTAB8107, GSE118828, GSE130000, and GSE154600 cohorts using the TISCH2 database. The ConsensusClusterPlus package was used to cluster the OV tumor tissues hierarchically to determine two molecularly different groups (C1 and C2). A total often different types of machine learning techniques with 101 combinations were used for prognostic model construction. Using eight TME algorithms integrated into the IOBR R package, the bulk RNA-seq dataset was analyzed. For in vitro experiments, OVCAR3 and SKOV3, two OV cell lines, were used. The migratory potential of the ovarian cancer cells was assessed using Transwell assay, while proliferation was assessed using CCK8 assay.  \nResults: Based on TME-related gene set expression, two distinct molecular subgroups (C1 and C2) were identified through consensus clustering, with C1 showing higher TME activity. Further analysis indicated that C1 had increased cancer-associated fibroblasts (CAFs), M1 macrophages, and CD8+ T cells, suggesting a more activated and pro-inflammatory TME. Drug sensitivity analysis revealed that 5-Fluorouracil might be beneficial to C1 patients. Functional differences between C1 and C2 were identified, including cell adhesion, mononuclear cell differentiation, and leukocyte migration. A machine learning model was developed to create a TME-related prognostic signature, demonstrating strong prognostic capabilities across multiple datasets. High-risk patients showed a more immune-suppressive TME and higher tumor stemness. ScRNA-seq disclosed a highly activated TME-related signature in OV. Cancer cell lines had significantly higher SH2D1A mRNA expression than normal ovarian epithelial cells. We observed that SH2D1Aknockdown in 2 ovarian cancer cell lines (OVCAR3 and SKOV3) reduced migration and proliferation through a series of in-vitro experiments.  \nConclusion: TME-associated genes were efficient in ovarian cancer molecular subtyping. A TMEbased prognosis model was constructed for vigorous prognostic stratification efficacy across  \n* Corresponding author. Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.  \n** Corresponding author. Department of Gynecology, The Children’s Hospital of Shanxi, Taiyuan, 030001, China.  \n*** Corresponding author. Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.  \n[E-mail addresses:](E-mail addresses: Xiaoli-010@163.com)[ Xiaoli-010@163.com](E-mail addresses: Xiaoli-010@163.com) (X. Li), [zsyprofessor@aliyun.com](zsyprofessor@aliyun.com) (S. Zhang), [xinglinyuan860807@163.com](xinglinyuan860807@163.com) (X. Zhang).  \n[https://doi.org/10.1016/j.heliyon.2024.e38014](https://doi.org/10.1016/j.heliyon.2024.e","cbCaioJeqw5PBvUB","https://ap.wps.com/l/cbCaioJeqw5PBvUB","pdf",19993597,17,"English","# Introduction\n## Methods\n## Results\n## Conclusion","[{\"question\":\"Why is ovarian cancer prognosis poor in this study?\",\"answer\":\"Ovarian cancer has a poor prognosis due to late-stage diagnosis and the limited availability of effective targeted therapies.\"},{\"question\":\"How were ovarian cancer molecular subgroups identified?\",\"answer\":\"Bulk RNA-seq data from multiple cohorts were clustered using consensus clustering to derive two molecularly distinct groups (C1 and C2) based on TME-related gene set expression.\"},{\"question\":\"What role does SH2D1A play according to the study?\",\"answer\":\"SH2D1A is highlighted as a key regulator of ovarian cancer carcinogenesis. Its knockdown in ovarian cancer cell lines reduces migration and proliferation in vitro.\"}]","Exploring tumor microenvironment in molecular subtyping and prognostic signatures in ovarian cancer and identification of SH2D1A as a key regulator of ovarian cancer carcinogenesis | PDF",1790016692,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcec3f3e7c2c34c744d40004d9ece819.webp",983,1341,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c656e5d97427ec5ae05ad11fe377712b.webp",982,1340,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/355309c6d5f40e41cacceeff35e1ee80.webp",981,1338,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/897c93927316fba8dd5e79c4bb3d42ee.webp",980,1337]